{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T00:12:48Z","timestamp":1780791168142,"version":"3.54.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T00:00:00Z","timestamp":1696550400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.vph.2023.107170","type":"journal-article","created":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T06:03:05Z","timestamp":1693461785000},"page":"107170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Antibody-mediated PCSK9 neutralization worsens outcome after bare-metal stent implantation in mice"],"prefix":"10.1016","volume":"153","author":[{"given":"Yustina M.","family":"Puspitasari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Ministrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Liberale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Vukolic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philine","family":"Baumann-Zumstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik W.","family":"Holy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Montecucco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"L\u00fcscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni G.","family":"Camici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vph.2023.107170_bb0005","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur. Heart J."},{"issue":"47","key":"10.1016\/j.vph.2023.107170_bb0010","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1093\/eurheartj\/ehv511","article-title":"Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Gr\u00fcntzig lecture ESC 2014","volume":"36","author":"Byrne","year":"2015","journal-title":"Eur. Heart J."},{"issue":"10","key":"10.1016\/j.vph.2023.107170_bb0015","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.jcin.2011.05.025","article-title":"Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis","volume":"4","author":"Inoue","year":"2011","journal-title":"JACC Cardiovasc Interv."},{"issue":"2","key":"10.1016\/j.vph.2023.107170_bb0020","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/cvr\/cvt115","article-title":"Biological responses in stented arteries","volume":"99","author":"Chaabane","year":"2013","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.vph.2023.107170_bb0025","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/eurheartj\/ehp259","article-title":"Rapamycin promotes arterial thrombosis in vivo: implications for everolimus and zotarolimus eluting stents","volume":"31","author":"Camici","year":"2010","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.vph.2023.107170_bb0030","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of drug-eluting stents in humans. Delayed healing and late thrombotic risk","volume":"48","author":"Joner","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.vph.2023.107170_bb0035","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/cvr\/cvz313","article-title":"PCSK9 and inflammation: role of shear stress, pro-inflammatory cytokines, and LOX-1","volume":"116","author":"Ding","year":"2020","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.vph.2023.107170_bb0040","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.atherosclerosis.2011.11.026","article-title":"Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levels","volume":"220","author":"Ferri","year":"2012","journal-title":"Atherosclerosis."},{"issue":"14","key":"10.1016\/j.vph.2023.107170_bb0045","doi-asserted-by":"crossref","DOI":"10.2174\/0929867324666170303123734","article-title":"Treatment with Proprotein convertase Subtilisin\/Kexin type 9 (PCSK9) inhibitors to reduce cardiovascular inflammation and outcomes","volume":"24","author":"Liberale","year":"2017","journal-title":"Curr. Med. Chem."},{"issue":"2","key":"10.1016\/j.vph.2023.107170_bb0050","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2174\/0929867328666210707192625","article-title":"PCSK 9: a link between inflammation and atherosclerosis","volume":"29","author":"Patriki","year":"2021","journal-title":"Curr. Med. Chem."},{"issue":"34","key":"10.1016\/j.vph.2023.107170_bb0055","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.vph.2023.107170_bb0060","series-title":"A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis","first-page":"1","author":"Simsekyilmaz","year":"2013"},{"issue":"11","key":"10.1016\/j.vph.2023.107170_bb0065","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13600","article-title":"TNF-\u03b1 antagonism rescues the effect of ageing on stroke: perspectives for targeting inflamm-ageing","volume":"51","author":"Liberale","year":"2021","journal-title":"Eur. J. Clin. Investig."},{"issue":"10","key":"10.1016\/j.vph.2023.107170_bb0070","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1093\/cvr\/cvab300","article-title":"MMP-2 knockdown blunts age-dependent carotid stiffness by decreasing elastin degradation and augmenting eNOS activation","volume":"118","author":"Diaz-Canestro","year":"2022","journal-title":"Cardiovasc. Res."},{"issue":"10","key":"10.1016\/j.vph.2023.107170_bb0075","doi-asserted-by":"crossref","first-page":"786","DOI":"10.5301\/ijao.5000336","article-title":"From histology and imaging data to models for in-stent restenosis","volume":"37","author":"Amatruda","year":"2014","journal-title":"Int J Artif Organs."},{"issue":"7","key":"10.1016\/j.vph.2023.107170_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232565","article-title":"An image J plugin for the high throughput image analysis of in vitro scratch wound healing assays","volume":"15","author":"Suarez-Arnedo","year":"2020","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.vph.2023.107170_bb0085","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.jid.2016.11.020","article-title":"Research techniques made simple: analysis of collective cell migration using the wound healing assay","volume":"137","author":"Grada","year":"2017","journal-title":"J Invest Dermatol."},{"issue":"10","key":"10.1016\/j.vph.2023.107170_bb0090","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1194\/jlr.M051326","article-title":"Alirocumab inhibits atherosclerosis, improves the plaque morphology, and enhances the effects of a statin","volume":"55","author":"K\u00fchnast","year":"2014","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.vph.2023.107170_bb0095","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/ar.1092260114","article-title":"Cross-sectional internal diameters of human cervical and femoral blood vessels: relationship to subject\u2019s sex, age, body size","volume":"226","author":"Mortensen","year":"1990","journal-title":"Anat. Rec."},{"issue":"45","key":"10.1016\/j.vph.2023.107170_bb0100","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1093\/eurheartj\/ehv100","article-title":"Coronary vascular regulation, remodelling, and collateralization: mechanisms and clinical implications on behalf of the working group on coronary pathophysiology and microcirculation","volume":"36","author":"Pries","year":"2015","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.vph.2023.107170_bb0105","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/cvr\/cvv178","article-title":"Cross-talk between LOX-1 and PCSK9 in vascular tissues","volume":"107","author":"Ding","year":"2015","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.vph.2023.107170_bb0110","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/ATVBAHA.121.316902","article-title":"PCSK9 (Proprotein convertase Subtilisin\/Kexin type 9) triggers vascular smooth muscle cell senescence and apoptosis: implication of its direct role in degenerative vascular disease","volume":"42","author":"Guo","year":"2022","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.vph.2023.107170_bb0115","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.tcb.2018.02.001","article-title":"Hallmarks of cellular senescence","volume":"28","author":"Hernandez-Segura","year":"2018","journal-title":"Trends Cell Biol."},{"issue":"10","key":"10.1016\/j.vph.2023.107170_bb0120","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1161\/ATVBAHA.119.313194","article-title":"ApoER2 (apolipoprotein E Receptor-2) deficiency accelerates smooth muscle cell senescence via cytokinesis impairment and promotes fibrotic Neointima after vascular injury","volume":"39","author":"Komaravolu","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.vph.2023.107170_bb0125","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/hh0402.105956","article-title":"Targeting CCR2 or CD18 inhibits experimental in-stent restenosis in primates: inhibitory potential depends on type of injury and leukocytes targeted","volume":"90","author":"Horvath","year":"2002","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.vph.2023.107170_bb0130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/01.ATV.16.1.12","article-title":"Proliferating arterial smooth muscle cells after balloon injury express TNF-\u03b1 but not interleukin-1 or basic fibroblast growth factor","volume":"16","author":"Tanaka","year":"1996","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.vph.2023.107170_bb0135","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11239-010-0471-7","article-title":"Inflammatory response to percutaneous coronary intervention in stable coronary artery disease","volume":"31","author":"Munk","year":"2011","journal-title":"J. Thromb. Thrombolysis"},{"issue":"2","key":"10.1016\/j.vph.2023.107170_bb0140","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/cvr\/cvt090","article-title":"The effects of stenting on shear stress: relevance to endothelial injury and repair","volume":"99","author":"Van Der Heiden","year":"2013","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.vph.2023.107170_bb0145","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1475-925X-8-8","article-title":"Evaluation of the effect of stent strut profile on shear stress distribution using statistical moments","volume":"8","author":"Mejia","year":"2009","journal-title":"Biomed. Eng. Online"},{"issue":"9","key":"10.1016\/j.vph.2023.107170_bb0150","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1089\/ars.2014.6054","article-title":"Hemodynamic shear stress via ROS modulates PCSK9 expression in human vascular endothelial and smooth muscle cells and along the mouse aorta","volume":"22","author":"Ding","year":"2015","journal-title":"Antioxid. Redox Signal."},{"issue":"4","key":"10.1016\/j.vph.2023.107170_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11883-018-0718-x","article-title":"Pleiotropic anti-atherosclerotic effects of PCSK9 InhibitorsFrom molecular biology to clinical translation","volume":"20","author":"Karagiannis","year":"2018","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.vph.2023.107170_bb0160","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.atherosclerosis.2017.04.023","article-title":"New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4\/NF-\u03baB pathway","volume":"262","author":"Tang","year":"2017","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.vph.2023.107170_bb0165","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.atherosclerosis.2016.07.910","article-title":"PCSK9 knock-out mice are protected from neointimal formation in response to perivascular carotid collar placement","volume":"253","author":"Ferri","year":"2016","journal-title":"Atherosclerosis."},{"issue":"4","key":"10.1016\/j.vph.2023.107170_bb0170","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jcin.2019.12.028","article-title":"A polymer-free paclitaxel-eluting stent versus a bare-metal stent for De novo Femoropopliteal lesions: the BATTLE trial","volume":"13","author":"Gou\u00ebffic","year":"2020","journal-title":"JACC Cardiovasc Interv."},{"issue":"21","key":"10.1016\/j.vph.2023.107170_bb0175","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1161\/CIRCULATIONAHA.122.059606","article-title":"Efficacy of a drug-eluting stent versus bare metal stents for symptomatic Femoropopliteal peripheral artery disease: primary results of the EMINENT randomized trial","volume":"146","author":"Gou\u00ebffic","year":"2022","journal-title":"Circulation."},{"issue":"1","key":"10.1016\/j.vph.2023.107170_bb0180","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/(SICI)1097-4644(20000401)77:1<116::AID-JCB12>3.0.CO;2-7","article-title":"A deficit in collagenase activity contributes to impaired migration of aged microvascular endothelial cells","volume":"77","author":"Reed","year":"2000","journal-title":"J. Cell. Biochem."},{"issue":"12","key":"10.1016\/j.vph.2023.107170_bb0185","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/gerona\/58.12.B1074","article-title":"Age-dependent decline of in vitro migration (basal and stimulated by IGF-1 or insulin) of human vascular smooth muscle cells","volume":"58","author":"Ruiz-Torres","year":"2003","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"17","key":"10.1016\/j.vph.2023.107170_bb0190","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1016\/j.cub.2017.07.033","article-title":"Unmasking transcriptional heterogeneity in senescent cells","volume":"27","author":"Hernandez-Segura","year":"2017","journal-title":"Curr. Biol."},{"issue":"4","key":"10.1016\/j.vph.2023.107170_bb0195","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1074\/jbc.M708098200","article-title":"The Proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2","volume":"283","author":"Poirier","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.vph.2023.107170_bb0200","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s40262-017-0620-7","article-title":"Clinical pharmacokinetics and pharmacodynamics of Evolocumab, a PCSK9 inhibitor","volume":"57","author":"Kasichayanula","year":"2018","journal-title":"Clin. Pharmacokinet."},{"issue":"3","key":"10.1016\/j.vph.2023.107170_bb0205","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1210\/endrev\/bnab035","article-title":"The multifaceted biology of PCSK9","volume":"43","author":"Seidah","year":"2022","journal-title":"Endocr. Rev."},{"issue":"3","key":"10.1016\/j.vph.2023.107170_bb0210","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.celrep.2014.03.043","article-title":"Cholesterol regulates Syntaxin 6 trafficking at trans-Golgi network endosomal boundaries","volume":"7","author":"Reverter","year":"2014","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.vph.2023.107170_bb0215","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1080\/19336918.2015.1019996","article-title":"The cross-talk of LDL-cholesterol with cell motility: insights from the Niemann pick type C1 mutation and altered integrin trafficking","volume":"9","author":"Hoque","year":"2015","journal-title":"Cell Adhes. Migr."},{"issue":"1","key":"10.1016\/j.vph.2023.107170_bb0220","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/CIRCULATIONAHA.120.046290","article-title":"PCSK9 (Proprotein convertase Subtilisin\/Kexin 9) enhances platelet activation, thrombosis, and myocardial infarct expansion by binding to platelet CD36","volume":"143","author":"Qi","year":"2021","journal-title":"Circulation."},{"issue":"11","key":"10.1016\/j.vph.2023.107170_bb0225","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.3390\/ijms22115880","article-title":"PCSK9 biology and its role in atherothrombosis","volume":"22","author":"Barale","year":"2021","journal-title":"Int J Mol Sci"}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189123000307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189123000307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T07:01:54Z","timestamp":1724655714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189123000307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":45,"alternative-id":["S1537189123000307"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2023.107170","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibody-mediated PCSK9 neutralization worsens outcome after bare-metal stent implantation in mice","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2023.107170","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107170"}}